Chronic Kidney Disease Screening and Renoprotection in Type 2 Diabetes
Ann. afr. med
; 8(1): 52-54, 2009.
Article
in English
| AIM
| ID: biblio-1259007
Responsible library:
CG1.1
ABSTRACT
Background:
Type 2 diabetes (T2D) is a major cause of chronic kidney disease. Control of hypertension and the use of angiotensin converting enzyme inhibitors (ACEI) and/or angiotensin II receptor blockers especially in those with proteinuria have been shown to protect against chronic kidney disease and delay its progression to kidney failure.Methods:
We reviewed the medical records of 169 patients at 12 months with a view of auditing the screening for chronic kidney disease and the use of renoprotective measures.Results:
Urinalysis was done in 49.1and serum creatinine in 50.3. No patient had glomerular filtration rate estimated. Seventy nine (67.6) of the hypertensive patients were on anti-hypertensives. ACEI was used in 49 (45.8) of these patients BP control was optimal in 29.1.Conclusion:
There is poor adherence to guidelines on chronic kidney disease screening and renoprotection in T2D
Search on Google
Index:
AIM (Africa)
Main subject:
Hypertension
/
Kidney Failure, Chronic
/
Nigeria
Type of study:
Diagnostic study
/
Screening study
Country/Region as subject:
Africa
Language:
English
Journal:
Ann. afr. med
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS